Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Campath and Trileptal
Link ID 1573
Title FDA Safety Changes: Campath and Trileptal
Url http://www.medscape.com/viewarticle/567322?src=rss
Description The FDA has approved revisions to the safety labeling for alemtuzumab intravenous injection (Campath) and oxcarbazepine tablets/oral suspension (Trileptal). Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Dec 14, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Use of Tumor Markers Low in Testis Cancer
  The use of tumor markers in testis cancer is low and varies considerably in the United States, despite the role markers can play in providing information pertinent to diagnosis, risk stratification, response to therapy, and disease recurrence. Medscape Medical News
Category:   Articles > Hematology-Oncology


2. Three Lots of Cytarabine for Injection Recalled Three Lots of Cytarabine for Injection Recalled
  There is a possibility that 3 specific lots of the drug, which is used in the treatment of leukemias, are not sterile. News Alerts
Category:   Articles > Hematology-Oncology


3. 2009 Genitourinary Cancers Symposium (GUCS)
  Read clinically focused news coverage of key developments from the meeting. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


4. Alemtuzumab Combo: Not the Ticket for CLL?Alemtuzumab Combo: Not the Ticket for CLL?
  Dr. Bruce Cheson says a new German study of alemtuzumab and fludarabine in relapsed CLL is somewhat irrelevant and the therapy significantly more toxic compared with other combination therapies. Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology


5. Fertility Preservation for Breast Cancer Patients
  Women of childbearing age with breast cancer who want to preserve their fertility now have several good options. Seminars in Reproductive Medicine
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS